ASNC President Announces Advocacy Win: Evicore Expands Coverage of PET Myocardial Blood Flow

Speaking at ASNC2023's Opening Plenary Session, Mouaz H. Al-Mallah, MD, MSc, MASNC, announced an advocacy win that speaks to ASNC's perseverance. For more than two years, ASNC leaders have been talking with Evicore about expanding their coverage policy to include PET myocardial blood flow (MBF). 

"As of now, Evicore no longer considers myocardial blood flow experimental," Dr. Al-Mallah announced. "This is an important success for ASNC and, more importantly, for patient care." 
The insurer's new policy now states that PET myocardial blood flow should be approved where –
  • Labs are accredited and interpreting physicians are board certified; and 
  • Labs have instituted a standard protocol and include reports with rest and stress MBF measurement as well as myocardial blood flow reserve reported as the ratio of stress to rest MBF. 
For the full list of coverage conditions, see pages 90-91 of Evicore's new policy